Effectiveness, safety, and health-related quality of life outcomes in patients with hemophilia A receiving antihemophilic factor (recombinant) in a real-world setting: results of a 6-year interim analysis of the AHEAD International study
Johannes Oldenburg
(1, 2)
,
Margareth C. Ozelo
(3)
,
Robert Klamroth
(4)
,
Benoît Guillet
(5)
,
Kate Khair
(6)
,
Dimitrios A. Tsakiris
(7)
,
Jaco Botha
,
Alejandro Fernandez-Martinez
,
Leilei Tang
,
Elena Santagostino
(8)
1
Bonn Universitat Clinique, Inst Expt Hematol and Transfus Med, Germany
2 University Hospital Bonn
3 UNICAMP - Universidade Estadual de Campinas = University of Campinas
4 Vivantes Klinikum Friedrichshain, Dept Internal Med Vasc Med and Haemostaseol, Germany
5 Irset - Institut de recherche en santé, environnement et travail
6 CHU London
7 CHU Basel
8 CHU Milan
2 University Hospital Bonn
3 UNICAMP - Universidade Estadual de Campinas = University of Campinas
4 Vivantes Klinikum Friedrichshain, Dept Internal Med Vasc Med and Haemostaseol, Germany
5 Irset - Institut de recherche en santé, environnement et travail
6 CHU London
7 CHU Basel
8 CHU Milan
Jaco Botha
- Fonction : Auteur
Alejandro Fernandez-Martinez
- Fonction : Auteur
- PersonId : 740077
- IdHAL : alejandro-fernandez-martinez
- ORCID : 0000-0001-5073-9629
- IdRef : 202645940
Leilei Tang
- Fonction : Auteur